Epsilon M&A Deal Report - Salveo Biotechnology Swiss Laboratory
Transaction Multiples for the Valuation of Private Companies
Cryo-Save Group (Now Esperite) / Salveo Biotechnology Swiss Laboratory
No EMAT :
71488
Announced Date :
14/05/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cryo-Save Group (Now Esperite)
Target :
Salveo Biotechnology Swiss Laboratory
Country :
Switzerland
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratories
Business Description :
The acquired activites consists of a Swiss private laboratory specialized in stem cells cryopreservation, cell culture and regenerative medicine activities and the central commercial and IT...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratories » = 130
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/05/2010 | VITA 34 International | Novel Pharma SL (Secuvita) | Spain | * | 71420 |
| 04/02/2015 | Shofu | Merz Dental | Germany | * | 71408 |
Source: Epsilon Research / EMAT
